Neuronetics is trading at $2.33, up 10.66%, amid broader-market strength, though no direct catalyst is confirmed.
- No confirmed new company-specific announcement was found for October 26, 2026. Neuronetics’ investor-relations news lists its November 4 third-quarter results announcement, released October 21.
- Reuters reported U.S. stock futures higher as oil prices retreated and investors looked ahead to earnings and the Federal Reserve decision. Available evidence supports a market-sentiment explanation, not a confirmed direct catalyst for the stock’s move.